Anti-Pneumococcal Vaccine-Induced Cellular Immune Responses in Post-Traumatic Splenectomized Individuals

Area of Science:

• Immunology
• Vaccinology
• Cellular immunology

Background:

• Splenectomy increases infection risk despite vaccination.
• Cellular immunity post-splenectomy is understudied.
• Understanding cellular responses can improve vaccine strategies.

Purpose of the Study:

• Investigate cellular immune responses to pneumococcal vaccines in splenectomized patients.
• Assess T-cell differentiation and cytokine release.
• Inform development of enhanced vaccination strategies.

Main Methods:

• Vaccination with pneumococcal conjugate (PCV) and polysaccharide vaccines.
• In vitro stimulation of peripheral blood mononuclear cells (PBMCs) with PCV.
• Assessed lymphoproliferation, T_H cell differentiation (T_H1, T_H17), and cytokine (IFN-γ, IL-4, IL-17) release.

Main Results:

• Asplenic patients showed significantly lower T_H1 cell differentiation.
• Reduced levels of lymphoproliferation, IFN-γ, IL-4, and IL-17 were observed in splenectomized individuals.
• Pneumococcal conjugate vaccine (PCV) failed to induce a T_H17 response.

Conclusions:

• Splenectomy negatively impacts PCV-induced lymphoproliferation, T_H1 differentiation, and cytokine release.
• Current vaccination strategies may be insufficient for optimal cellular immunity in asplenic patients.
• Further research is needed to enhance vaccine efficacy against extracellular pathogens in this population.